SecBot SecBot
SECBOTREPLAY Home › Report › SLDB

SLDB · Solid Biosciences is holding its 2026 annual meeting with several key…

Solid Biosciences Inc. · DEFA14A filed Apr 23, 2026 at 16:07 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Apr 23, 2026 at 16:07 ET

Solid Biosciences is holding its 2026 annual meeting with several key proposals, including the ratification of Ilan Ganot's board appointment, a share increase to 480 million, and advisory votes on executive compensation. This follows a recent board reshuffle where Ganot was reappointed to a different class, indicating ongoing governance adjustments.

  • Election of Class II directors Clare Kahn, Adam Stone, and Lynne Sullivan
  • Ratification of Ilan Ganot's appointment to Class I director
  • Ratification of PricewaterhouseCoopers as independent auditor
  • Proposal to increase authorized shares from 240M to 480M

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access